BenQ Medical Technology Corporation

TPEX:4116 Voorraadrapport

Marktkapitalisatie: NT$2.2b

BenQ Medical Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

BenQ Medical Technology heeft een totaal eigen vermogen van NT$2.1B en een totale schuld van NT$1.1B, wat de schuld-eigenvermogensverhouding op 54.2% brengt. De totale activa en totale passiva bedragen respectievelijk NT$4.6B en NT$2.5B. De EBIT BenQ Medical Technology is NT$365.2M waardoor de rentedekking 16.2 is. Het heeft contanten en kortetermijnbeleggingen van NT$941.7M.

Belangrijke informatie

54.2%

Verhouding schuld/eigen vermogen

NT$1.14b

Schuld

Rente dekkingsratio16.2x
ContantNT$941.66m
AandelenNT$2.10b
Totaal verplichtingenNT$2.52b
Totaal activaNT$4.62b

Recente financiële gezondheidsupdates

BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

Jan 29
BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

Recent updates

There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Apr 07
There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

Mar 23
Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Mar 08
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

Feb 17
Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

Jan 29
BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 11
BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

Dec 24
The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Dec 07
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Nov 17
Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$2.6B ) 4116 } overtreffen de korte termijn passiva ( NT$1.4B ).

Langlopende schulden: De kortetermijnactiva 4116 ( NT$2.6B ) overtreffen de langetermijnschulden ( NT$1.1B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 9.2% ) 4116 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 4116 is de afgelopen 5 jaar gestegen van 14.7% naar 54.2%.

Schuldendekking: De schuld van 4116 wordt goed gedekt door de operationele kasstroom ( 35.8% ).

Rentedekking: De rentebetalingen op de schuld van 4116 worden goed gedekt door EBIT ( 16.2 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y